ID22073A - Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase - Google Patents

Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase

Info

Publication number
ID22073A
ID22073A IDW990564A ID990564A ID22073A ID 22073 A ID22073 A ID 22073A ID W990564 A IDW990564 A ID W990564A ID 990564 A ID990564 A ID 990564A ID 22073 A ID22073 A ID 22073A
Authority
ID
Indonesia
Prior art keywords
tiobenzena
nitromethy
aldosa
decreased
reducing
Prior art date
Application number
IDW990564A
Other languages
English (en)
Indonesian (id)
Inventor
Francois Collonges
Herve Dumas
Claude Lardy
Philippe Durbin
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID22073A publication Critical patent/ID22073A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/40Y being a hydrogen or a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/42Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/49Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IDW990564A 1996-12-23 1997-12-12 Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase ID22073A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615887A FR2757509B1 (fr) 1996-12-23 1996-12-23 Nouveaux derives de sulfonamides et sulfonylurees, leurs preparations et medicaments les contenant

Publications (1)

Publication Number Publication Date
ID22073A true ID22073A (id) 1999-09-02

Family

ID=9499031

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990564A ID22073A (id) 1996-12-23 1997-12-12 Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase

Country Status (24)

Country Link
US (2) US6509499B1 (es)
EP (1) EP0946503B1 (es)
JP (1) JP2001507001A (es)
KR (1) KR20000069678A (es)
CN (1) CN1112356C (es)
AT (1) ATE215069T1 (es)
AU (1) AU728562B2 (es)
BR (1) BR9714069A (es)
CA (1) CA2275665A1 (es)
CZ (1) CZ227799A3 (es)
DE (1) DE69711429T2 (es)
DK (1) DK0946503T3 (es)
ES (1) ES2172829T3 (es)
FR (1) FR2757509B1 (es)
HU (1) HUP0002054A3 (es)
ID (1) ID22073A (es)
NO (1) NO313325B1 (es)
PL (1) PL334188A1 (es)
PT (1) PT946503E (es)
RU (1) RU2184110C2 (es)
SK (1) SK282820B6 (es)
TR (1) TR199901442T2 (es)
UA (1) UA56205C2 (es)
WO (1) WO1998028265A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2884820B1 (fr) * 2005-04-25 2007-07-27 Merck Sante Soc Par Actions Si Nouveaux inhibiteurs specifiques de la caspase-10
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions
DE3835200A1 (de) * 1988-10-15 1990-05-03 Bayer Ag Fluoralkyl-schwefel-arylverbindungen, deren verwendung, deren herstellung und vorprodukte zu deren herstellung
IE63463B1 (en) * 1989-02-06 1995-04-19 Zeneca Ltd Phenylsulphone derivatives
US5120876A (en) * 1989-11-29 1992-06-09 E. I. Du Pont De Nemours And Company Fluorinated sulfones/ketones for nonlinear optics
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5250570A (en) 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
GB9016980D0 (en) * 1990-08-02 1990-09-19 Ici Plc Amidobenzenes
GB9016984D0 (en) 1990-08-02 1990-09-19 Ici Plc Aniline derivatives

Also Published As

Publication number Publication date
KR20000069678A (ko) 2000-11-25
JP2001507001A (ja) 2001-05-29
FR2757509A1 (fr) 1998-06-26
DE69711429D1 (en) 2002-05-02
FR2757509B1 (fr) 1999-03-26
SK282820B6 (sk) 2002-12-03
DE69711429T2 (de) 2002-10-31
WO1998028265A1 (fr) 1998-07-02
US20030203966A1 (en) 2003-10-30
UA56205C2 (uk) 2003-05-15
HUP0002054A3 (en) 2002-09-30
NO313325B1 (no) 2002-09-16
ES2172829T3 (es) 2002-10-01
PT946503E (pt) 2002-09-30
EP0946503A1 (fr) 1999-10-06
HUP0002054A2 (hu) 2000-11-28
CZ227799A3 (cs) 1999-11-17
NO993082L (no) 1999-08-20
ATE215069T1 (de) 2002-04-15
RU2184110C2 (ru) 2002-06-27
PL334188A1 (en) 2000-02-14
SK83399A3 (en) 1999-12-10
TR199901442T2 (xx) 1999-09-21
CA2275665A1 (en) 1998-07-02
AU5757198A (en) 1998-07-17
AU728562B2 (en) 2001-01-11
US6509499B1 (en) 2003-01-21
NO993082D0 (no) 1999-06-22
EP0946503B1 (fr) 2002-03-27
DK0946503T3 (da) 2002-06-10
BR9714069A (pt) 2000-05-09
CN1241997A (zh) 2000-01-19
CN1112356C (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
AU7404791A (en) Treatment of cataract with 15-keto-prostaglandin compounds
TNSN94104A1 (fr) Composes carbamates tricycliques utiles pour l'inhibition de la fonction proteine g et pour le traitement des maladies proliferatives
MY106259A (en) 2-aminopyrimidinone derivatives.
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
EP0379806A3 (en) Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
NO924915D0 (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
AU1628597A (en) Treatment and prophylaxis of pancreatitis
ID22073A (id) Turunan-turunan nitrometil tiobenzena sebagai bahan penghambat aldosa reduktase
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
AU2693697A (en) Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of medicaments intended for the normalization of the endothelial function, for the treatment of sexual dysfunction and vascular complications of diabetes, as well as vascular disorders of endothelial origin
TW245717B (es)
CA2030344A1 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
EP0378146A3 (en) Polyamine derivatives as antineoplastic agents
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ATE133161T1 (de) (p-carbonylaminophenyl)- sulphonylnitromethanderivate
EG16563A (en) Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones
WO2001035948A3 (en) Neurophilin ligands for treating ocular conditions
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.